Mabpharm Limited (HK:2181)
:2181
Hong Kong Market

Mabpharm Limited (2181) Financial Statements

Compare
0 Followers

Mabpharm Limited Financial Overview

Mabpharm Limited's market cap is currently HK$2.19B. The company's EPS TTM is HK$-0.033; its P/E ratio is ―; Mabpharm Limited is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue¥ 87.16M¥ 55.92M¥ 82.88M¥ 0.00¥ 14.07M
Gross Profit¥ 75.24M¥ 40.54M¥ 66.11M¥ 0.00¥ 14.07M
Operating Income¥ -201.98M¥ -203.83M¥ -289.27M¥ -180.69M¥ -194.83M
EBITDA¥ -139.08M¥ -152.08M¥ -245.46M¥ -169.93M¥ -172.64M
Net Income¥ -209.36M¥ -210.62M¥ -294.22M¥ -188.57M¥ -210.22M
Balance Sheet
Cash & Short-Term Investments¥ 173.34M¥ 48.61M¥ 81.56M¥ 484.85M¥ 767.88M
Total Assets¥ 1.03B¥ 917.52M¥ 899.90M¥ 1.16B¥ 1.40B
Total Debt¥ 260.07M¥ 126.34M¥ 45.69M¥ 40.35M¥ 105.62M
Net Debt¥ 86.73M¥ 92.77M¥ -35.87M¥ -444.50M¥ -483.10M
Total Liabilities¥ 829.92M¥ 516.58M¥ 297.92M¥ 281.55M¥ 342.77M
Stockholders' Equity¥ 205.06M¥ 400.94M¥ 601.98M¥ 881.49M¥ 1.05B
Cash Flow
Free Cash Flow¥ 38.35M¥ -182.01M¥ -348.14M¥ -344.47M¥ -250.19M
Operating Cash Flow¥ 57.39M¥ -56.88M¥ -199.47M¥ -147.23M¥ -136.62M
Investing Cash Flow¥ -3.50M¥ -104.95M¥ -179.42M¥ 156.00M¥ -413.09M
Financing Cash Flow¥ 85.60M¥ 112.26M¥ -17.78M¥ -80.48M¥ 922.76M
Currency in CNY

Mabpharm Limited Earnings and Revenue History

Mabpharm Limited Debt to Assets

Mabpharm Limited Cash Flow

Mabpharm Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis